Holmusk, Veradigm Announce New Phase of Strategic Investment to Fuel Innovation and Close the Evidence Gap in Behavioral Health
02 Ottobre 2023 - 2:01PM
Business Wire
Expanded database will enable deeper analysis
and insights to enhance care delivery and improve behavioral health
outcomes
Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare
data and technology solutions, and Holmusk, a leading global
behavioral health real-world evidence company, today jointly
announced the next stage in its strategic collaboration.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231002562008/en/
The collaboration draws on the strengths of each company to fuel
innovation in behavioral health and create the evidence needed to
move the field forward. In this new phase of the collaboration,
cohorts of millions of behavioral health patients and related
de-identified clinical data from Veradigm will be added to
Holmusk’s NeuroBlu Database, a leading source for real-world data
that shows how behavioral health care is delivered. Veradigm is
also making an additional financial investment in Holmusk, building
on a collaboration launched early this year, when Veradigm became
the lead investor in Holmusk’s Series B financing round.
“This strategic investment represents significant growth for our
NeuroBlu Database, enabling us to move closer to our vision of
creating a single source of truth for behavioral health,” said
Nawal Roy, Holmusk’s founder and CEO. “This is a crucial step as we
work to help eliminate the gaps in evidence, information, and
learning that have held the behavioral health industry back from
moving to an outcome-based reimbursement system and a learning
healthcare system.”
The collaboration expands Holmusk’s NeuroBlu Database by
millions of patients. The NeuroBlu Database will now be able to
power even more research and address challenging behavioral health
questions that require the creation of targeted research
cohorts.
“We look forward to taking this next step in our collaboration
with Holmusk,” said Rick Poulton, Veradigm’s Chief Executive
Officer. “Holmusk’s expertise in preparing clinical real-world data
for analysis, including mapping the data to a common data model,
will be invaluable in unlocking new insights from our existing
resources. We also believe it will enable the creation of
much-needed evidence to improve behavioral health outcomes around
the world.”
About Holmusk
Holmusk is on a mission to harness real-world data to transform
both research and care for behavioral health. Combining the leading
behavioral health database with AI-powered analytics and digital
solutions designed to address the most pressing challenges in
behavioral health, Holmusk is advancing the frontier of evidence
generation and fueling innovation. Holmusk is headquartered in New
York, with four additional offices around the world. For more
information, please visit www.holmusk.com.
About Veradigm®
Veradigm is a healthcare technology company that drives value
through its unique combination of platforms, data, expertise,
connectivity, and scale. The Veradigm Network features a dynamic
community of solutions and partners providing advanced insights,
technology, and data-driven solutions, all working together to
transform healthcare insightfully. For more information on
Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn,
Facebook, Twitter, and YouTube.
© 2023 Veradigm Inc. and/or its affiliates. All Rights
Reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231002562008/en/
Investors: Jenny Gelinas
312-506-1237 jenny.gelinas@veradigm.com
Media: Concetta Rasiarmos
312-447-2466 concetta.rasiarmos@veradigm.com
Paul Feldhausen 608-658-9561 paul.feldhausen@holmusk.com
Grafico Azioni Veradigm (NASDAQ:MDRX)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Veradigm (NASDAQ:MDRX)
Storico
Da Mag 2023 a Mag 2024